Symptoms Following Discontinuation of Tyrosine Kinase Inhibitor (TKI) Therapy After Achieving an Adequate Response in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

被引：0

作者：

Ritchie, Ellen K. ^{[1
]}

Sadek, Islam ^{[2
]}

Pivneva, Irina ^{[3
]}

Guerin, Annie ^{[3
]}

Latremouille-Viau, Dominick ^{[3
]}

Ndife, Briana ^{[2
]}

Joseph, George J. ^{[2
]}

Atallah, Ehab L. ^{[4
]}

机构：

[1] Weill Cornell Med Coll, New York, NY USA

[2] Novartis Pharmaceut, E Hanover, NJ USA

[3] Anal Grp Inc, Montreal, PQ, Canada

[4] Med Coll Wisconsin, Milwaukee, WI 53226 USA

来源：

关键词：

chronic myeloid leukemia; treatment discontinuation; treatment-free remission; tyrosine kinase inhibitor;

D O I：

10.1016/j.clml.2018.07.091

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CML-046

引用

页码：S221 / S222

页数：2